FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1319-1320 April 25, 2002 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Frey, S. E. Related Article by Bicknell, W. J. PubMed Citation

The recent cases of anthrax due to bioterrorism and the terrorist attacks of September 11, 2001, have led to an unprecedented degree of concern and urgency regarding the vulnerability of our society to more such attacks.¹ At the Department of Health and Human Services, efforts to counter bioterrorism are focused on a group of pathogenic microbes that include Bacillus anthracis (the cause of anthrax), variola virus (the cause of smallpox), Yersinia pestis (the cause of plague), Francisella tularensis (the cause of tularemia), Clostridium botulinum (which causes botulism), and the hemorrhagic-fever viruses such as Ebola.¹ Within this group, smallpox stands out . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Yu, C. I., Gallegos, M., Marches, F., Zurawski, G., Ramilo, O., Garcia-Sastre, A., Banchereau, J., Palucka, A. K. (2008). Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood 112: 3671-3678 [Abstract] [Full Text]  
• Perera, L. P., Waldmann, T. A., Mosca, J. D., Baldwin, N., Berzofsky, J. A., Oh, S.-K. (2007). Development of Smallpox Vaccine Candidates with Integrated Interleukin-15 That Demonstrate Superior Immunogenicity, Efficacy, and Safety in Mice. J. Virol. 81: 8774-8783 [Abstract] [Full Text]  
• Lee, E. K., Maheshwary, S., Mason, J., Glisson, W. (2006). Large-Scale Dispensing for Emergency Response to Bioterrorism and Infectious-Disease Outbreak. Interfaces 36: 591-607 [Abstract]  
• Gofin, R. (2005). Preparedness and response to terrorism: A framework for public health action. Eur J Public Health 15: 100-104 [Abstract] [Full Text]  
• Selgelid, M J (2004). Bioterrorism and smallpox planning: information and voluntary vaccination. J. Med. Ethics 30: 558-560 [Abstract] [Full Text]  
• Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., Ahmed, R. (2003). Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination. J. Immunol. 171: 4969-4973 [Abstract] [Full Text]  
• Wright, M. E., Fauci, A. S. (2003). Smallpox Immunization in the 21st Century: The Old and the New. JAMA 289: 3306-3308 [Full Text]  
• Booss, J., Davis, L. E. (2003). Smallpox and smallpox vaccination: Neurological implications. Neurology 60: 1241-1245 [Abstract] [Full Text]  
• Lane, J. M., Goldstein, J. (2003). Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options. ANN INTERN MED 138: 488-493 [Abstract] [Full Text]  
• Blendon, R. J., DesRoches, C. M., Benson, J. M., Herrmann, M. J., Taylor-Clark, K., Weldon, K. J. (2003). The Public and the Smallpox Threat. NEJM 348: 426-432 [Abstract] [Full Text]  
• Halloran, M. E., Longini, I. M. Jr., Nizam, A., Yang, Y. (2002). Containing Bioterrorist Smallpox. Science 298: 1428-1432 [Abstract] [Full Text]  
• Frist, B. (2002). Public Health And National Security: The Critical Role Of Increased Federal Support. Health Aff (Millwood) 21: 117-130 [Abstract] [Full Text]  
• Neff, J. M., Lane, J. M., Fulginiti, V. A., Henderson, D. A. (2002). Contact Vaccinia--Transmission of Vaccinia From Smallpox Vaccination. JAMA 288: 1901-1905 [Full Text]  
• Committee on Infectious Diseases, (2002). Smallpox Vaccine. Pediatrics 110: 841-845 [Abstract] [Full Text]  
• (2002). Smallpox in Theory and Practice: Controversies Abound. JWatch General 2002: 1-1 [Full Text]